Skip to content
Search

Latest Stories

Submit Guest Post

Review launched into Lucy Letby case after experts challenge evidence

On Tuesday, her legal team applied to the independent Criminal Cases Review Commission (CCRC) to examine whether there had been a possible miscarriage of justice in her trials in 2023 and 2024.

Lucy Letby

Letby, 35, is serving 15 whole-life sentences for the deaths of babies at neo-natal units in northwest England between 2015 and 2016.

A REVIEW has been launched into the case of Lucy Letby, a nurse sentenced to life imprisonment for killing seven newborn babies, as medical experts argue there was no evidence to support her conviction.

Letby, 35, is serving 15 whole-life sentences for the deaths of babies at neo-natal units in northwest England between 2015 and 2016. She was convicted of murdering seven newborns and attempting to kill seven others at the Countess of Chester Hospital, making her the most prolific child serial killer in modern UK history.


On Tuesday, her legal team applied to the independent Criminal Cases Review Commission (CCRC) to examine whether there had been a possible miscarriage of justice in her trials in 2023 and 2024.

Letby maintains her innocence and was accused of harming the babies using various methods, including injecting air into their bloodstreams, leading to sudden and unexpected collapses.

Shoo Lee, a retired Canadian doctor whose 1989 academic paper on air embolism was cited in Letby's 10-month trial, told a press conference that the evidence presented against her was flawed.

"The evidence that was used to convict her was wrong and for me that is a problem," he said, adding that Letby had exhausted all appeals.

He was speaking in London alongside an international panel of 14 independent experts in neonatal care, who concluded that their findings did not support murder in any of the cases.

Letby’s lawyer, Mark McDonald, described Tuesday’s evidence as having "demolished" the medical findings used in her trial.'Major injustice'

A CCRC spokesperson confirmed that a preliminary application had been received and that work had begun to assess it. The commission has the power to refer cases back to the Court of Appeal if it finds a possible miscarriage of justice.

"It is not for the CCRC to determine innocence or guilt ... that's a matter for the courts," the spokesperson said.

Instead, the commission’s role is to investigate and refer cases if new evidence suggests a conviction might not be upheld or a sentence could be reduced.

Former Conservative minister David Davis, who has raised concerns about Letby’s case in Parliament, described her convictions as "one of the major injustices of modern times."

Letby previously lost two appeals in 2023, with judges rejecting fresh evidence from Lee. They ruled that there had been no prosecution expert evidence diagnosing air embolus based solely on skin discolouration.

A public inquiry into the wider circumstances of the case began in September and is ongoing.

(With inputs from AFP)

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Jio

Nita and Mukesh Ambani stand ahead of the listing of Jio Platforms Limited during its IPO at the National Stock Exchange (NSE) in Mumbai, October 28, 2026.

Reuters

Tearful Mukesh Ambani watches Jio debut make Reliance India’s most valuable group

  • Jio shares jump 27 per cent on debut in Mumbai
  • Listing values Jio at around $137 billion (£102 billion)
  • Reliance group overtakes Tata as India’s most valuable business empire
  • Mukesh Ambani in tears as his children speak at the listing ceremony

SHARES in Mukesh Ambani’s Reliance Jio Platforms soared 27 per cent on their stock market debut in Mumbai on Wednesday, making it India’s second most valuable company after its parent, Reliance Industries.

The listing values Jio at around $137 billion (£102 billion), overtaking Bharti Airtel and HDFC Bank. It also lifted the combined value of the Reliance group to $320 billion (£239 billion), making it India’s most valuable business group ahead of the Tata Group.

Keep ReadingShow less